Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Category icon
Cardiac Pacing in Reflex Syncope

Marco Tomaino, Vincenzo Russo, Daniele Giacopelli, et al

Category icon
Left Bundle Branch Pacing: A Perfect Compromise?

Alexandre Raymond-Paquin, Santosh K Padala, Kenneth A Ellenbogen,

Category icon
SVT Discrimination Using CV Implantable Electronic Devices

Rahul K Mukherjee, Manav Sohal, Nesan Shanmugam, et al

Category icon
Adenosine Test in Syncope of Unknown Origin

Melani Sotiriadou, Antonios P Antoniadis, Nikolaos Fragakis, et al

Category icon
Permanent Pacing of the Conduction Axis

José-Ángel Cabrera, Robert H Anderson, Andreu Porta-Sánchez, et al

Category icon
Physiology and Practicality of Left Ventricular Septal Pacing

Luuk Heckman, Justin Luermans, Floor Salden, et al

Category icon
Implantable Cardiac Monitoring

Jan Steffel, Thomas Pezawas, Clare Newbery

Category icon
A Quick Guide to Paravalvular Leak Closure

Sameer Gafoor, Jennifer Franke, Stefan Bertog, et al

Category icon
Asia Pacific Online Symposium on Cardiac Rhythm Management

Dr. John Ip, Dr. Hiro Yamasaki, Prof. Kyoko Soejima et al

Category icon
Biology of the Sinus Node and its Disease

Moinuddin Choudhury, Mark R Boyett, Gwilym M Morris,

Category icon
Risk Stratification in Hypertrophic Cardiomyopathy

Alexandros Klavdios Steriotis, Sanjay Sharma,

Category icon
Baroreflex Activation Therapy for the Treatment of HFrEF

Faiez Zannad, Jörn Schmitt , Ainhoa Robles Mezcua et al

Category icon
Syncope in the Elderly

Helen O’Brien, Rose Anne Kenny,

Category icon
Mahaim Accessory Pathways

Demosthenes G Katritsis, Hein J Wellens, Mark E Josephson,

Category icon
Asia Pacific Online Symposium on Cardiac Rhythm Management

Shu Zhang, Seow Swee Chong, David O’Donnell et al

About

Cardiac pacing is a well-established therapeutic tool improving the survival and quality of life in patients. Indications for permanent cardiac pacing include sinus node dysfunction, intermittent and incomplete atrioventricular block, and bundle branch block.

Cardiac pacing, in conjunction with beta-blocker therapy, can potentially reduce the risk of bradycardia-dependent QT prolongation, decrease heart-rate irregularities and reduce repolarisation heterogeneity.

Cardiac resynchronisation therapy (CRT) with biventricular pacing is an effective therapy in patients with advanced heart failure (HF) – New York Heart Association (NYHA) Class III or IV, an ejection fraction (EF) 120 ms.

CRT has also been shown to be effective for the prevention of HF in relatively asymptomatic patients with wide QRS. However, CRT is underutilised among eligible patients. Approximately one-third of patients do not respond to CRT due to various factors, including anatomic difficulties and suboptimal lead placement. To increase the effectiveness of CRT, it has been hypothesised that pacing at multiple left ventricular (LV) sites may provide more effective resynchronisation.

In clinical studies, use of MultiPoint pacing in HF patients undergoing CRT has been associated with increased haemodynamic and clinical benefits compared with conventional pacing, particularly in patients with the least improvement from biventricular pacing.

Related Articles

Articles

Cardiac Pacing in Reflex Syncope

Marco Tomaino, Vincenzo Russo, Daniele Giacopelli,

Published:

Citation: Arrhythmia & Electrophysiology Review 2021;10(4):244–9.

Left Bundle Branch Pacing: A Perfect Compromise?

Alexandre Raymond-Paquin, Santosh K Padala, Kenneth A Ellenbogen,

Published:

Citation: Arrhythmia & Electrophysiology Review 2021;10(4):241–3.

2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy

Gheorghe-Andrei Dan,

Published:

Citation: European Cardiology Review 2021;16:e55.

SVT Discrimination Using CV Implantable Electronic Devices

Rahul K Mukherjee, Manav Sohal, Nesan Shanmugam,

Published:

Citation: Arrhythmia & Electrophysiology Review 2021;10(4):235–40.